Uncategorized

It’s ironic that the future of the Affordable Care Act (“ACA;” “Obamacare”), with it’s all-consuming scope that impacts 1/6 of the U.S. economy under the guise of healthcare reform, may reside with the vote of the nine jurists on the Supreme Court. In all likelihood, the actual outcome will rest with just two, Justices’ Roberts […]

Good news for plans sponsors who want to reduce their prescription drug costs: generics will continue to be used instead of brands. Bad news: these generics will continue to escalate in cost! The huge jump in many generics during 2014 was not a one-time anomaly.   We expect that generics will continue to rise, and coupled […]

The future of the Affordable Care Act (“ACA” or “Obamacare”) is hinging on the outcome of King v. Burwell. The Supreme Court is expected to rule before the end of June and 6.5 million folks who currently receive subsidies, are nervously awaiting the decision. The promise of healthcare reform, i.e., that the uninsured would receive […]